生物标志物预测认知障碍在院外心脏骤停后神经功能良好幸存者中可行
研究纳入79例CPC≤2的院外心脏骤停幸存者,来自TTH48试验两个中心,比较33±1°C下TTM 48小时 vs 24小时。在到达及达温后24、48、72小时测S-100b和NSE,6个月时用13项认知测试评估,全局认知障碍定义为至少3项测试z<-1.67。认知障碍发生率为22%,以记忆损害最常见。NSE 48小时预测认知障碍敏感度100%、特异度56%,预测性能不受TTM时长影响。
要点
- CPC≤2的OHCA幸存者中22%存在认知障碍,记忆损害最常见,提示CPC不能替代神经心理评估。
- 达温后48小时NSE预测6个月认知障碍:敏感度100%、特异度56%,可作为早期风险分层参考。
- NSE 48小时的预测性能不受TTM 48小时 vs 24小时影响,两种TTM时长下均可解读。
- S-100b和NSE与多个认知域评分显著相关,但原文未给出具体相关系数。
- 该研究为TTH48试验两个中心的二次分析,N=79,结论需外部验证。
适用人群与场景
- 来自TTH48试验两个中心的院外心脏骤停幸存者,N=79,CPC评分≤2,接受33±1°C目标温度管理。
- 排除人群原文未提及;场景为ICU住院期间生物标志物监测及6个月认知随访。
诊断标准与关键阈值
- 全局认知障碍定义:13项认知测试中至少3项z<-1.67。
- 神经功能良好定义:CPC评分≤2。
- 生物标志物采样时间点:到达时及达到33±1°C目标温度后24、48、72小时。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:TTH48试验两个中心的二次分析,N=79,CPC≤2的OHCA幸存者。
- 干预:33±1°C下TTM 48小时 vs 24小时;主要终点为6个月认知障碍(13项测试中至少3项z<-1.67)。
- 认知障碍发生率22%,记忆损害最常见;NSE 48小时预测认知障碍敏感度100%、特异度56%。
- NSE 48小时预测性能不受TTM时长影响;S-100b和NSE与多个认知域评分显著相关(原文未给具体数值)。
证据类型、等级与局限
- 证据类型:基于RCT(TTH48)的二次分析,两个中心,样本量79。
- 局限:样本量小、仅两个中心、认知障碍定义基于z-score阈值、未报告外部验证;原文未给出证据等级。
对床旁实践的改变
- 对CPC≤2的OHCA幸存者,达温后48小时NSE可辅助早期识别6个月认知障碍高风险患者,敏感度100%但特异度56%,不能单独用于确诊。
- TTM 48小时与24小时下NSE 48小时的预测性能一致,临床解读时无需按TTM时长调整。
- CPC≤2不代表无认知障碍,出院前应关注记忆等认知域损害;原文未提及具体干预措施。
指南或共识出处
- TTH48试验(原文提及的比较TTM 48小时 vs 24小时 at 33±1°C的试验)。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Patients surviving out-of hospital cardicac arrest, with good neurological outcome according to Cerebral Performance Category, frequently have neuropsychological impairment. We studied whether biomarker data (S-100b and neuron-specific enolase) obtained during the ICU stay predicted cognitive impairment 6 months after resuscitation.
METHODS: Patients (N = 79) with a CPC-score ≤2 were recruited from two trial sites taking part in the TTH48 trial comparing targeted temperature management (TTM) for 48 h vs. 24 h at 33 ± 1 °C. We assessed patients 6 months after the OHCA. We measured biomarkers S-100b and NSE at arrival and at 24, 48 and 72 h after reaching the target temperature of 33 ± 1 °C. Four cognitive domain z-scores were calculated, and global cognitive impairment was defined as z < -1.67 on at least 3 out of 13 cognitive tests. Non-parametric correlations were used to assess the relationship between cognitive domain and biomarkers. ROC curves were used to assess prediction of cognitive impairment from the biomarkers. Logistic regression was used to investigate whether TTM duration moderated biomarker prediction of cognitive impairment.
RESULTS: Cognitive impairment was present in 22% of the patients with memory impairment being the most common. The biomarkers correlated significantly with several cognitive domain scores and NSE at 48 h predicted cognitive impairment with 100% sensitivity and 56% specificity. The predictive properties of NSE at 48 h was unaffected by duration of TTM.
CONCLUSIONS: Early biomarker prognostication of cognitive impairment is feasible even in OHCA survivors with good neurological outcome as defined by CPC. NSE at 48 h predicted cognitive impairment.
参考来源
- Brønnick K, Evald L, Duez CHV, et al. Biomarker prognostication of cognitive impairment may be feasible even in out-of hospital cardical arrest survivors with good neurological outcome. Resuscitation. 2021. PMID: 33631291. doi:10.1016/j.resuscitation.2021.02.025
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。